Sun Pharmaceutical Industries Limited Share Price and Company Fundamentals
Last traded: Today at 9:59 AM
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.
Key Metrics
PE ratio
40.02
PB ratio
5.95
Dividend yield
0.84%
Beta
0.53
Market cap
-
Enterprise value
-
Company profile
| Industry / Sector | Drug Manufacturers—Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 41000 |
| Website | https://www.sunpharma.com |
| Mailing address | Sun House Plot No. 201 B/1 Western Express Highway Goregaon (East) Mumbai 400063 India |
| Phone / Fax | 91 22 4324 4324 / 91 22 4324 4343 |
Dividends
Dividend yield
0.84%
Dividend amount
₹12.50
Payout ratio
31.00%
5Y Avg. yield
0.93%
Sun Pharmaceutical Industries Limited paid ₹12.50 dividend and the ex-dividend date was 09 Feb 2024.The dividend payout ratio is 31.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.SUNPHARMA dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
SUNPHARMA's forward dividend amount is ₹12.5 and the forward dividend yield is 0.84%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
Company Executives
As of Apr 2024, following are the company executives and directors listed on Sun Pharmaceutical Industries Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Dilip Shantilal Shanghvi | MD & Executive Director | 68 | 54.53M |
| Mr. Kalyanasundaram Subramanian | Director of Corporate Development | 69 | 65.3M |
| Mr. C. S. Muralidharan | Chief Financial Officer | 60 | 38.89M |
| Mr. Davinder Singh | Executive Vice-President of Global Operations | ||
| Mr. Dheeraj Prasad Sinha BE | EVP & Chief Information Officer | 52 | |
| Mr. Nimish Desai | Head of Investor Relations | ||
| Mr. Anoop Deshpande | Company Secretary & Compliance Officer | ||
| Mr. Suresh Kumar Rai | Chief Human Resources Officer | ||
| Mr. Kirti Wardhaman Ganorkar | Chief Executive Officer of India Business | 56 | |
| Mr. Aalok Dilip Shanghvi | Executive VP, Head of Emerging Markets, Global Generics R&D, Business Devp., and Whole Time Director | 39 |
Profitability and management effectiveness
Profit margin
18.77%
Operating margin
22.05%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Sun Pharmaceutical Industries Limited is and its enterprise value is .
The SUNPHARMA's stocks Beta value is 0.53 making it 47% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Frequently Asked Questions
1. What is Sun Pharmaceutical Industries Limited's Stock Symbol?
Sun Pharmaceutical Industries Limited trades on NSE under the ticker symbol "SUNPHARMA".
2. What is Sun Pharmaceutical Industries Limited's stock price today?
One share of SUNPHARMA stock can currently be purchased for approximately ₹1485.75.
3. How can I contact Sun Pharmaceutical Industries Limited?
Sun Pharmaceutical Industries Limited's mailing address is Sun House Plot No. 201 B/1 Western Express Highway Goregaon (East) Mumbai 400063 India. The company can be reached via phone at 91 22 4324 4324.
4. What is Sun Pharmaceutical Industries Limited's official website?
The official website of Sun Pharmaceutical Industries Limited is https://www.sunpharma.com.